Trials / Sponsors / Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NS Metastatic Non-squamous Non Small Cell Lung Cancer | Phase 3 | 2021-12-08 |
| Active Not Recruiting | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell | Phase 1 | 2017-09-20 |
| Completed | Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases | Phase 1 | 2016-09-01 |